RIPK4
Basic information
Region (hg38): 21:41739369-41767089
Previous symbols: [ "ANKRD3" ]
Links
Phenotypes
GenCC
Source:
- Bartsocas-Papas syndrome 1 (Supportive), mode of inheritance: AR
- Bartsocas-Papas syndrome 1 (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Bartsocas-Papas syndrome 1; CHAND syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Genitourinary; Musculoskeletal; Ophthalmologic | 4339984; 10925380; 15264293; 23074676; 22197489; 22197488; 26129644; 28940926 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RIPK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 39 | 12 | 59 | |||
missense | 75 | 87 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 36 | 21 | 26 | 83 | ||
Total | 0 | 2 | 119 | 69 | 40 |
Variants in RIPK4
This is a list of pathogenic ClinVar variants found in the RIPK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-41739391-T-G | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739418-A-C | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739462-G-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Apr 27, 2017) | ||
21-41739477-A-T | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41739590-G-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41739604-C-T | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41739632-T-C | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739635-T-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739646-T-C | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739666-A-G | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41739687-C-T | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739721-A-G | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739757-G-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41739798-A-AC | Popliteal pterygium syndrome | Uncertain significance (Jun 14, 2016) | ||
21-41739813-C-A | Bartsocas-Papas syndrome 1 | Benign (Apr 27, 2017) | ||
21-41739855-C-T | Bartsocas-Papas syndrome 1 | Benign (Apr 27, 2017) | ||
21-41739860-G-C | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41739877-C-T | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41740014-G-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) | ||
21-41740015-T-C | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 13, 2018) | ||
21-41740054-A-ACT | Popliteal pterygium syndrome | Benign (Jun 14, 2016) | ||
21-41740090-T-C | Bartsocas-Papas syndrome 1 | Likely benign (Apr 27, 2017) | ||
21-41740091-A-T | Bartsocas-Papas syndrome 1 | Benign (Apr 27, 2017) | ||
21-41740097-C-T | Bartsocas-Papas syndrome 1 | Likely benign (Apr 27, 2017) | ||
21-41740109-G-A | Bartsocas-Papas syndrome 1 | Uncertain significance (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RIPK4 | protein_coding | protein_coding | ENST00000332512 | 8 | 27738 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00396 | 0.996 | 125491 | 0 | 257 | 125748 | 0.00102 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.89 | 409 | 532 | 0.769 | 0.0000377 | 5032 |
Missense in Polyphen | 134 | 207.51 | 0.64574 | 2011 | ||
Synonymous | -1.31 | 278 | 252 | 1.11 | 0.0000196 | 1659 |
Loss of Function | 3.15 | 9 | 26.5 | 0.340 | 0.00000139 | 282 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000562 | 0.000558 |
Ashkenazi Jewish | 0.00326 | 0.00318 |
East Asian | 0.000438 | 0.000435 |
Finnish | 0.00103 | 0.000878 |
European (Non-Finnish) | 0.00157 | 0.00148 |
Middle Eastern | 0.000438 | 0.000435 |
South Asian | 0.000131 | 0.000131 |
Other | 0.00135 | 0.00130 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in stratified epithelial development. It is a direct transcriptional target of TP63. Plays a role in NF-kappa-B activation. {ECO:0000269|PubMed:12446564, ECO:0000269|PubMed:22197488}.;
- Disease
- DISEASE: Popliteal pterygium syndrome, lethal type (PPS-L) [MIM:263650]: An autosomal recessive disorder characterized by multiple popliteal pterygia leading to severe arthrogryposis, ankyloblepharon filiforme adnatum, filiform bands between the jaws, synostosis of the carpal/tarsal and phalangeal bones in the hands and feet, digital hypoplasia/aplasia, complete soft-tissue syndactyly, lack of nails, lack of scalp hair, eyebrows and eyelashes, blepharophimosis, cleft lip and/or palate, and hypoplastic external genitalia. Early lethality is common, although survival into childhood and beyond has been reported. {ECO:0000269|PubMed:22197488, ECO:0000269|PubMed:22197489}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.172
Intolerance Scores
- loftool
- 0.382
- rvis_EVS
- -1.66
- rvis_percentile_EVS
- 2.75
Haploinsufficiency Scores
- pHI
- 0.217
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.684
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ripk4
- Phenotype
- integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype;
Gene ontology
- Biological process
- morphogenesis of an epithelium;protein phosphorylation;positive regulation of NF-kappaB transcription factor activity
- Cellular component
- cytoplasm;membrane
- Molecular function
- protein serine/threonine kinase activity;protein binding;ATP binding